Excerpt:

(OMNS October 12, 2010) In massive doses, vitamin C (ascorbic acid) stops a cold within hours, stops influenza in a day or two, and stops viral pneumonia (pain, fever, cough) in two or three days. (1) It is a highly effective antihistamine, antiviral and antitoxin. It reduces inflammation and lowers fever. Administered intravenously, ascorbate kills cancer cells without harming healthy tissue. Many people therefore wonder, in the face of statements like these, why the medical professions have not embraced vitamin C therapy with open and grateful arms.

Probably the main roadblock to widespread examination and utilization of this all-too-simple technology is the equally widespread belief that there must be unknown dangers to tens of thousands of milligrams of ascorbic acid. Yet, since the time megascorbate therapy was introduced in the late 1940’s by Fred R. Klenner, M.D. (2), there has been an especially safe, and extremely effective track record to follow.

Still, for some, questions remain. Here is a sample of what readers have asked OMNS about vitamin C:

Is 2,000 mg/day of vitamin C a megadose? 
No. Decades ago, Linus Pauling and Irwin Stone showed that most animals make at least that much (or more) per human body weight per day. (3,4)

Then why has the government set the “Safe Upper Limit for vitamin C at 2,000 mg/day? 
Perhaps the reason is ignorance. According to nationwide data compiled by the American Association of Poison Control Centers, vitamin C (and the use of any other dietary supplement) does not kill anyone. (5)

Does vitamin C damage DNA? 
No. If vitamin C harmed DNA, why do most animals make (not eat, but make) between 2,000 and 10,000 milligrams of vitamin C per human equivalent body weight per day? Evolution would never so favor anything that harms vital genetic material. White blood cells and male reproductive fluids contain unusually high quantities of ascorbate. Living, reproducing systems love vitamin C.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
Reproductive Research Center, Glickman Urological Institute and Department of
Obstetrics-Gynecology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
agarwaa@ccf.org

OBJECTIVE: To investigate the effect of cell phone use on various markers of
semen quality.

DESIGN: Observational study.

SETTING: Infertility clinic.

PATIENT(S): Three hundred sixty-one men undergoing infertility evaluation were
divided into four groups according to their active cell phone use: group A: no
use; group B: <2 h/day; group C: 2-4 h/day; and group D: >4 h/day.

INTERVENTION(S): None.

MAIN OUTCOME MEASURE(S): Sperm parameters (volume, liquefaction time, pH, viscosity, sperm count, motility, viability, and morphology).

RESULT(S): The comparisons of mean sperm count, motility, viability, and normal morphology among four different cell phone user groups were statistically significant. Mean sperm motility, viability, and normal morphology were significantly different in cell phone user groups within two sperm count groups. The laboratory values of the above four sperm parameters decreased in all four cell phone user groups as the duration of daily exposure to cell phones increased.

CONCLUSION(S): Use of cell phones decrease the semen quality in men by
decreasing the sperm count, motility, viability, and normal morphology. The
decrease in sperm parameters was dependent on the duration of daily exposure to
cell phones and independent of the initial semen quality.

Linda’s comment:  Several of us have been trying for years to get the Department of Health to classify Lyme disease as an STD.  Doctors including Lyme Literate Medical Doctors=LLMD’s, are split.  We now know that Lyme can be sexually transmitted.  It makes sense to classify Lyme as STD.  We need to do all we can to help stop the spread of Lyme and Company.  I suggest when talking to your children about their sexual activities, to strongly warn them about the chance of getting sexually transmitted Lyme.

One in Four Teenage Girls Have STDs

Getty Images/Comstock Images

By Deborah Huso

According to a report just released from the U.S. Centers for Disease Control (CDC), One in four teenage girls has or has had a sexually transmitted disease (STD). The research shows that many of these girls are infected soon after their first sexual encounter, leading to renewed calls for better sexual health education among teens.

The study followed over 800 girls between the ages of 14 and 19. Among the STDs the researchers tracked were gonorrhea, Chlamydia, herpes simplex virus type 2 and human papillomavirus (HPV). Twenty-four percent of study participants were infected with one of more of these STDs. Of that 24 percent, more than 18 percent were infected with HPV, the presence of which can eventually lead to cervical cancer.

Teenage girls also accounted for the greatest number of reported cases of Chlamydia and gonorrhea, outpacing women in their early 20s. The study also showed that African American teens and young women are particularly vulnerable to STDs. Black teenage girls have the highest rates of Chlamydia and gonorrhea infection of any racial or age group.

“We cannot ignore the glaring racial disparities in rates of STDs, particularly when we consider the hard truth that gonorrhea rates among African Americans are 20 times those of whites,” says John M. Douglas, Jr., M.D., director of CDC’s Division of STD Prevention. He cites lack of access to quality health care as a major cause of the prevalence of STDs in minority communities.

As for the high rates of STDs among female teens, study authors claim public reluctance to talk about sexual health is largely to blame. “STDs are hidden epidemics of enormous health and economic consequence in the United States,” the study authors claim.

“We know adolescent girls and minorities are most impacted by STDs,” says Kevin Fenton, M.D., director of CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention. “So it is up to us as a nation to reach out to them and ensure we are providing the necessary prevention, testing and treatment services.”

Authors of the newly released study strongly advocate that girls between 11 and 12 years of age should get the HPV vaccine, and they also advocate annual testing for Chlamydia, which if left untreated can lead to both infertility and pelvic inflammatory disease, in teenage girls and young women.